About This CAT Score Calculator
This CAT Score Calculator provides a simple and efficient way to administer the COPD Assessment Test. This validated questionnaire is designed to quantify the impact of Chronic Obstructive Pulmonary Disease (COPD) symptoms on a patient’s daily life and well-being. The total score helps clinicians and patients have a more structured conversation about health status, guiding treatment decisions and allowing for monitoring of progress over time.
Scoring System Explained
The test consists of 8 questions, each covering a specific domain affected by COPD. The patient selects a response on a scale from 0 (no impact) to 5 (maximum impact). The CAT Score Calculator sums the points from all 8 questions to produce a total score out of 40.
Interpretation of Total Score
| Score Range | Impact Level on Health Status |
|---|
| 0-9 | Low Impact |
| 10-20 | Medium Impact |
| 21-30 | High Impact |
| 31-40 | Very High Impact |
Clinical Interpretation & Limitations
The CAT score is a key component of the multidimensional GOLD (Global Initiative for Chronic Obstructive Lung Disease) assessment strategy for COPD management.
- GOLD Grouping: Along with the patient’s exacerbation history and mMRC dyspnea score, the CAT (now CAAT) score helps classify patients into groups A, B, or E (GOLD merged the former C and D groups into Group E in 2023). A CAT score of ≥10 generally places a patient in a higher-symptom group (B or E), suggesting a need for more intensive bronchodilator therapy.
- Monitoring: Tracking the CAT score over time can help assess the effectiveness of treatment. A decrease of 2 or more points is considered a clinically significant improvement.
Limitations
The CAT score is a subjective measure of the patient’s perception of their health and can be influenced by other factors, such as mood disorders or other comorbidities. It complements but does not replace objective measurements of lung function like spirometry (FEV₁).
Frequently Asked Questions (FAQ)
1. What is a “good” or “bad” CAT score?
A lower score is better. A score under 10 indicates a “Low Impact” from COPD on the patient’s life, whereas a score over 20 indicates a “High” or “Very High Impact,” suggesting significant symptom burden.
2. How is the CAT score used to guide treatment?
In the GOLD guidelines, the CAT score is a primary tool for assessing symptom burden. A patient with few exacerbations but a CAT score of ≥10 (Group B) would be a candidate for dual bronchodilator therapy, whereas a patient with the same exacerbation history but a score <10 (Group A) might only require a single bronchodilator.
3. How often should the CAT score be measured?
The CAT should be measured at the initial diagnosis of COPD and at subsequent follow-up visits (e.g., every 3-6 months) to monitor the disease and response to therapy.
4. What is the difference between the CAT score and the mMRC dyspnea scale?
The mMRC scale only measures breathlessness (dyspnea). The CAT Score Calculator is much more comprehensive, assessing a wider range of factors including cough, phlegm, chest tightness, sleep, energy, and confidence, providing a broader picture of the patient’s overall health status.
5. What is the Minimal Clinically Important Difference (MCID) for the CAT score?
A change (either an increase or decrease) of 2 or more points is considered the MCID. This means a 2-point shift represents a real, noticeable change in the patient’s condition.
Related Calculators
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.
